Position in GILD
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$7,423,233
-$568,800 QoQ
Shares Held
58,756
+2.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
#489
of 2,266 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ascent Wealth Partners, LLC holds $36,435,678 across 7 Drug Manufacturers - General names. GILD ranks #2 (20.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
64,219 | $16,160,069 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
58,756 | $7,423,233 | |
| 3 | AMGN |
Amgen Inc
|
14,199 | $5,141,741 | |
| 4 | NVS |
Novartis AG
|
16,473 | $2,581,648 | |
| 5 | MRK |
Merck & Co., Inc.
|
17,254 | $2,217,139 | |
| 6 | PFE |
Pfizer Inc
|
89,916 | $2,165,177 | |
| 7 | JNJ |
Johnson & Johnson
|
2,940 | $746,671 |
All Filings in GILD
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,423,233 | 58,756 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $7,992,033 | 57,344 | Shares | Sole | 2026-05-06 | |
| No filing history on record for this holder in this stock. | ||||||